Table 3 Physician agreement with the evidence for tPA use in acute stroke care (n = 429)
Statement | Disagree/strongly disagree n (%) | Unsure n (%) | Agree/strongly agree n (%) |
|---|---|---|---|
Increasing appropriate use of tPA will: | |||
 Save lives | 185 (43.1) | 155 (36.1) | 89 (20.7) |
 Not result in unnecessary adverse events | 267 (62.3) | 102 (23.8) | 60 (14.0) |
 Improve the odds of independent survival for stroke patients | 109 (25.4) | 150 (35.0) | 170 (39.6) |
The evidence underpinning tPA use:* | |||
 Is strong when administered within 4.5 h of stroke onset | 226 (54.4) | 119 (28.7) | 70 (16.8) |
 Indicates that the benefits outweigh the risks if the treatment protocol is followed | 134 (32.3) | 107 (25.8) | 173 (42.0) |
 Is strong enough to warrant the use of this treatment | 141 (34.0) | 119 (28.7) | 155 (37.4) |